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Abstract
Background: Distress after prostate cancer treatment is a substantial burden for up to one-third of men diagnosed. Physical and
emotional symptoms and health service use can intensify, yet men are reticent to accept support. To provide accessible support
that can be cost effectively integrated into care pathways, we developed a unique, Web-based, self-guided, cognitive-behavior
program incorporating filmed and interactive peer support.
Objective: To assess feasibility of the intervention among men experiencing distress after prostate cancer treatment. Demand,
acceptability, change in distress and self-efficacy, and challenges for implementation in clinical practice were measured.
Methods: A pre-post, within-participant comparison, mixed-methods research design was followed. Phase I and II were conducted
in primary care psychological service and secondary care cancer service, respectively. Men received clinician-generated postal
invitations: phase I, 432 men diagnosed <5 years; phase II, 606 men diagnosed <3.5 years. Consent was Web-based. Men with
mild and moderate distress were enrolled. Web-based assessment included demographic, disease, treatment characteristics; distress
(General Health Questionnaire-28); depression (Patient Health Questionnaire-9); anxiety (General Anxiety Disorder Scale-7);
self-efficacy (Self-Efficacy for Symptom Control Inventory); satisfaction (author-generated, Likert-type questionnaire). Uptake
and adherence were assessed with reference to the persuasive systems design model. Telephone interviews explored participant
experience (phase II, n=10); interviews with health care professionals (n=3) explored implementation issues.
Results: A total of 135 men consented (phase I, 61/432, 14.1%; phase II, 74/606, 12.2%); from 96 eligible men screened for
distress, 32% (30/96) entered the intervention (phase I, n=10; phase II, n=20). Twenty-four completed the Web-based program
and assessments (phase I, n=8; phase II, n=16). Adherence for phase I and II was module completion rate 63% (mean 2.5, SD
1.9) versus 92% (mean 3.7, SD 1.0); rate of completing cognitive behavior therapy exercises 77% (mean 16.1, SD 6.2) versus
88% (mean 18.6, SD 3.9). Chat room activity occurred among 63% (5/8) and 75% (12/16) of men, respectively. In phase I, 75%
(6/8) of men viewed all the films; in phase II, the total number of unique views weekly was 16, 11, 11, and 10, respectively. The
phase II mood diary was completed by 100% (16/16) of men. Satisfaction was high for the program and films. Limited efficacy
testing indicated improvement in distress baseline to post intervention: phase I, P=.03, r=−.55; phase II, P=.001, r=−.59.
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Self-efficacy improved for coping P=.02, r=−.41. Service assessment confirmed ease of assimilation into clinical practice and
clarified health care practitioner roles.
Conclusions: The Web-based program is acceptable and innovative in clinical practice. It was endorsed by patients and has
potential to positively impact the experience of men with distress after prostate cancer treatment. It can potentially be delivered
in a stepped model of psychological support in primary or secondary care. Feasibility evidence is compelling, supporting further
evaluative research to determine clinical and cost effectiveness.
(JMIR Cancer 2018;4(1):e8)   doi:10.2196/cancer.8918
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Introduction
Need for Psychological Support
In developed regions of the world, men are more likely to be
diagnosed with prostate cancer than any other cancer, and those
diagnosed are more likely to develop distress or serious
psychological problems than healthy men [1,2]. Over 60% of
men with prostate cancer report unmet psychological needs and
up to a third experience pronounced clinical distress [3-7]. They
also have a higher risk of suicide than their healthy male
counterparts [8]. A range of factors contribute to men’s
psychological comorbidity. Side effects of treatment such as
urinary, sexual, bowel, and body-image problems can have a
negative effect on cancer-related distress for as much as 2-3
years after diagnosis [9-11], and men’s psychological well-being
can be adversely affected by lack of support, the threat of cancer,
and the perceived loss of masculine identity [12-14].
The numbers of men with prostate cancer living with and beyond
diagnosis are predicted to grow. There are over 1.1 million new
prostate cancer cases globally per year, accounting for some
15% of all cancer diagnoses in men [2]. Incidence varies but
trends indicate increasing diagnoses and decreasing mortality
rates, particularly in developed countries and where screening
programs have been implemented [15]. Five-year survival rates
now exceed 84% in Western Europe and approach 100% in the
United States and Australia [16-18], and in the United Kingdom
for instance, incidence rates are expected to rise by 12%, to over
77,000 new cases per year by 2035 [19]. The growing number
surviving prostate cancer means there will be more men
experiencing reduced psychological well-being and quality of
life, resulting in increased care utilization and health service
costs. Innovative, accessible, and low-cost care delivery
solutions are required to meet this long-term challenge.
Providing early psychological support is vital to ensure men
experiencing distress after prostate cancer treatment do not fall
into a cycle of negative thinking and avoidance behaviors, which
can escalate symptoms and lead to the need for more intensive,
prolonged support [5,6]. However, men’s engagement with
psychological support is frequently restrained: reticence to
communicate and delays in presenting to clinicians are
underpinned by fears of stigmatization and the desire to
normalize their illness experience by not needing help [20]. To
support men’s psychological needs, it is essential to develop
interventions that address these barriers.
Web-Based Support
The effectiveness of cognitive behavior therapy (CBT) is well
documented; it can offer an acceptable, brief intervention within
mental health services for people experiencing emotional
difficulties as a consequence of comorbid problem(s) [21,22].
More recently, Web-based CBT has proved as effective as CBT
delivered face-to-face [23]. However, there is mixed evidence
for the role of clinician guidance in Web-based interventions.
Although clinician support has been considered important for
beneficial outcomes, there is evidence to suggest that the level
of training for those providing guidance may be of limited
importance; in some cases therapist effect may be minimal, and
support can equally come from nonclinicians [23,24].
Conversely, a recent review concluded that there is limited
evidence to show that self-guided interventions, in any delivery
mode, can reduce psychological distress after cancer, but the
authors did consider that efficacy may be increased if
interventions are targeted at people formally assessed as being
distressed [25]. Notably, recent meta-synthesis of qualitative
studies in long-term conditions established that building
Web-based social ties with peers can support self-management
and improve illness experiences in aspects that are hard for
individuals to negotiate offline [26].
Web-based CBT for cancer patients, and prostate cancer in
particular, is a less-developed area compared with other chronic
physical conditions [27-31]. For men with prostate cancer,
Web-based delivery of psychological support is promising, it
can facilitate access and engagement by providing a faceless,
perceptually private environment to ameliorate men’s fears of
stigmatization; it can also prove cost-effective for health
services. A systematic review has shown that psychological
interventions for prostate cancer survivors can improve mental
health [32], but although 10 of the 21 effective patient-focused
interventions identified were based on or contained components
of CBT, only 2 were Web-based interventions. Both showed
an improvement in depression [33] or distress [31], but neither
of the interventions was carried out among a sample of men
who had been formally assessed as being distressed nor were
they delivered within a clinical setting. Outcomes from these
studies are more relevant to worried prostate cancer patients
than to a clinically distressed prostate cancer population
requiring a therapeutic service.
Study Aim
In this study, we describe the development and feasibility of
delivering a Web-based intervention in clinical practice for men
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with mild and moderate distress after treatment for prostate
cancer. The program offers self-guided CBT augmented with
filmed peer support and low-level chat room facilitation to
encourage self-management; it aims to offer men the ability to
monitor their condition and to affect the cognitive, behavioral,
and emotional responses necessary to maintain an acceptable
level of psychological well-being [32,34,35]. The program is
intended to provide a cost-effective, brief intervention that can
be offered through health services with minimal practitioner
input. Reflecting recommended foci for feasibility studies [36],
we assessed (1) demand through uptake and attrition, (2)
acceptability by adherence and participant satisfaction, (3)
potential for improvement in distress (and self-efficacy phase
II) through limited efficacy testing, and (4) potential challenges
for implementation in clinical practice.
Methods
Study Design
We conducted 2 phases of feasibility research. Phase I assessed
the program prototype in a low-intensity, primary care
psychological service within which it was developed. Data from
that phase informed further development, and phase II tested a
slightly revised version in a secondary care cancer service.
The studies were approved by the UK NHS National Research
Ethics Service, phase I reference 13/SC/0065; phase II reference
15/SC/0690.
In accordance with the Medical Research Council framework
for developing and evaluating complex interventions [37], we
used a pre-post, within-participant comparison, mixed-methods
design in both phases. In phase II, sequential qualitative
interviews were conducted after the final assessments to provide
complementary context to the data [38]. In phase I, the
intervention ran in February and again in March 2015, with
separate facilitators and participant cohorts. In phase II, the
intervention ran once with a single cohort and facilitator in June
2016.
Participants, Setting, and Recruitment
Identification, eligibility, and screening are outlined in Figure
1. Men diagnosed with prostate cancer, not receiving palliative
care for metastatic disease, were invited. In phase I, 432 men
diagnosed up to 5 years were invited by a letter from their
primary care physician; in phase II, 606 men diagnosed up to
3.5 years were invited by a letter from a nurse consultant in a
secondary care cancer service. The letter contained full
participant information and a link to the study website where
all further contact took place. Interested men visited the website
and gave informed consent. Consented men were then assessed
for eligibility and those eligible were screened for distress. Men
experiencing mild distress and men experiencing moderate
distress were asked to complete the remainder of baseline
assessments and were offered the intervention. (All inclusion
and exclusion criteria are summarized in Table 1.) A
risk-assessment protocol was administered throughout phases
I and II (see Multimedia Appendix 1).
Figure 1. Identification, eligibility, and screening.
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Table 1. Inclusion and exclusion criteria.
Phase IIPhase IInclusion and Exclusion
Men diagnosed with prostate cancer in last 3.5 yearsMen diagnosed with prostate cancer in last 5 yearsInclusion
Received or receiving treatment: prostatectomy, radiotherapy,
brachytherapy, hormone therapy, active surveillance, or
watchful waiting
Received or receiving treatment: prostatectomy, radiotherapy,
brachytherapy, hormone therapy, active surveillance, or
watchful waiting
Experiencing mild and moderate distressExperiencing mild and moderate distress
Palliative metastatic diseasePalliative metastatic diseaseExclusion
Referral or medication for memory lossReferral or medication for memory loss
(Men were not excluded on the basis of counseling or psy-
chiatric referral)
Counseling or psychiatric referral since diagnosis
Experiencing severe depression or suicidal thoughtsExperiencing severe depression or suicidal thoughts
Intervention
The program concept was developed from our previous research
in urinary symptom self-management after prostate cancer
treatment [39]. In response to a custom-made motivational peer
support film used in the randomized controlled trial of that
intervention, service users requested self-guided, easily
accessible support to help manage their psychological distress.
This need was confirmed in a scoping review of available
psychological care, literature review of the status of
cancer-related psychological interventions [40], and emerging
policy initiatives to provide psychological support within
primary care services for people struggling with a chronic
condition.
The Web-based program, Getting Down to Coping, was
produced in conjunction with a low-intensity psychological
service that accepted general physician and self-referrals. The
service was part of England’s National Health Service,
Improving Access to Psychological Therapies (IAPT) program,
which offered low- or high-intensity therapy, or referral to
specialist mental health services [41]. Particular features
included the use of standardized and manualized evidence-based
CBT and routine outcome monitoring at each clinical session.
The low-intensity service typically offered brief courses for
people with mild and moderate anxiety or depression, mostly
by telephone, but face-to-face and computer-based support was
available. Published evaluations have reported recovery rates
in excess of 50%, supporting service objectives, and IAPT is
now developing services to provide tailored support for people
with mental health needs associated with a long-term physical
condition [42,43].
The research team, in collaboration with a software engineer,
senior mental health practitioners, urologist, psychosexual
therapist, specialist nurse, and 3 user representatives,
codeveloped the initial program prototype based on the
manualized short course of CBT delivered by the service. The
course was then tailored to reflect prostate cancer-related
examples and concerns and supplemented with links to medical,
physical, emotional, social, and financial prostate cancer
information. The program website was styled with graphics and
language to appeal to a male audience and to reduce
connotations of mental health.
A fundamental component of the program was peer support,
but providing this over the internet is complex. Active
engagement with others through posting messages can mediate
positive outcomes, but not all men are prepared to do this, and
evidence shows that passively viewing messages is not
associated with the same beneficial outcomes [31,44]. To
support men, we embedded theory-driven peer support films
[45], as well as a platform for interactive support via an
asynchronous chat forum. A single chat forum thread ran
weekly; each week the facilitator started the thread by posting
a question relevant to the module topic. The program was
beta-tested by service users and the films were evaluated in
focus groups. Comments from users and research participants
were incorporated to refine the program and films.
The program contained 4 weekly, consecutive CBT modules
with an introduction at the beginning of Module 1 (see
Multimedia Appendix 2). It was intended that men should spend
up to an hour per week on each module, including chat room
activity. Modules were available 1 each week and progress was
sequential. A male narrator supported the text. Men were invited
to create a profile that other men could view. All worksheets
and materials were available to download.
The IAPT service used the Patient Health Questionnaire-9
(PHQ-9) [46] and the General Anxiety Disorder-7 scale
(GAD-7) for outcome monitoring [47]. To mirror the service’s
practice, these were administered weekly within the program
at the beginning of each module. Except in a situation of risk,
it was intended that no formal feedback from these measures
would be given to participants. In phase II, the measures were
replaced with a noncompulsory weekly mood diary that invited
participants to rate how they were feeling on 5 scales:
down/cheerful, irritable/calm, vulnerable/in control,
weary/active, and worried/relaxed; participants had the
opportunity to review their previous scores. Phase II
incorporated email notifications of chat room posts, chat room
access from any page, easier navigation, and frequently asked
questions for IT support. (screenshots in Figure 2.)
The prototype was developed with hard-coded software, which
limited functionality. For phase II, the program was redeveloped
within a content management system to enable integration into
clinical practice and facilitate further research.
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Figure 2. Screenshots of the Getting Down to Coping Program.
Facilitation
There were 3 chat room facilitators, each responsible for 1
cohort of men and all were trained by a subteam of researchers,
clinicians, and user representatives. Training covered Web-based
facilitation, prostate cancer issues, and/or CBT theory. In phase
I, 2 low-intensity psychological practitioners from the
collaborating service carried out facilitation. Each practitioner
allotted 2, predesignated 2-h slots per week to facilitate the chat
forum for their cohort. They also visited the website
intermittently during office hours to assess risk. During these
slots, the practitioners did not continue with their usual clinical
caseload. In phase II, a specialist cancer nurse delivered
facilitation and accessed and interacted with the program on an
ad hoc basis during the time it was available to participants.
Data Collection
Uptake
Uptake was assessed as the proportion of men who took up the
initial invitation, visited the website, and gave their consent.
Sample Characteristics
Demographic, disease, and treatment characteristics were
collected in both phases from eligible participants before distress
screening. Comorbidity was assessed separately at baseline in
phase I and post intervention in phase II.
Screening and Outcome Assessment
Distress screening took place at baseline 2 weeks before the
intervention; the remaining baseline assessments were completed
1 week before the intervention. Participants who entered the
intervention were followed-up and assessed through the website
in the week after intervention completion.
Attrition
Attrition was assessed by the number of men offered the
intervention who dropped out before, during, or after the
program and the proportion of core users who continued to use
the program [48].
Adherence
Adherence is an important mediating variable for benefit in
health-related Web-based interventions, yet it is a challenge to
achieve and measure [49,50]. We assessed adherence using the
persuasive system design (PSD) model [50,51], which proposes
that the content of Web-based behavior-change programs is
conveyed by a range of design features that can persuade and
motivate the user without deception, coercion or inducement
[52]. Design features can account for more than half the variance
in adherence, but researchers have been slow to take account
of this [50,52]. The PSD model advances 4 principles of design
support through which an interactive system can persuade and
enhance use: (1) support given to the primary task to
communicate meaningful content, (2) support given to a
dialogue between the program and the participant to help
participants move toward their goal, (3) support provided
through social features of the program to enhance participant
motivation, and (4) credibility support that makes the system
trustworthy and believable [51]. The Getting Down to Coping
program contained elements of all 4 principles; in particular,
quantifiable elements were located in task support and social
support (Table 2). We also assessed static measures: time
logged-in in phase I, time logged-in-and-active in phase II
defined as follows: (1) any action within 10 min of a previous
action would be considered to take place within the same session
and (2) the user would be expected to look at the site for 1 min
after their last action. We examined adherence among core users
[48].
JMIR Cancer 2018 | vol. 4 | iss. 1 | e8 | p.5http://cancer.jmir.org/2018/1/e8/
(page number not for citation purposes)
Cockle-Hearne et alJMIR CANCER
XSL•FO
RenderX
Table 2. Persuasive system design principles reflected in the Getting Down to Coping Program.
Getting Down to Coping Program componentsPSD elementsaPSDa principles [51]
Content delivered in sequential modules that can only be
accessed when the system releases the next module; Oppor-
tunities to self-assess and review progress.
Tunneling: Using the system to guide users through a process
of experience provides opportunities to persuade along the
way.
Supporting the primary
task
Program is prostate cancer focused throughout in respect of
context, examples, and suggestions; Provides targeted links
to Web-based information, education, and support services.
Tailoring: Information provided by the system will be more
persuasive if it is tailored to the potential needs, interest,
personality, usage context, or other factors relevant to a user
group.
In phase II, mood diary and CBT entries are available for
back reference once completed.
Self-monitoring: A system that keeps track of a user’s own
performance or status supports the user in achieving goals.
Emails from the system announce the imminent beginning
of each module; In phase II, email notifications are sent to
all chat room users when someone posts.
Reminders: If a system reminds users of their target behavior,
or that the system is ready to use, the users will more likely
achieve their goals.
Supporting the computer-
human dialogue
Text and voice over provide suggestions for action.Suggestions: Systems offering fitting suggestions will have
greater persuasive powers.
Graphics and layout are attractive and pertinent to men, films
show men in similar situations, and language is inclusive
and colloquial. Narrator (Robert) conveys familiarity.
Similarity: People are more readily persuaded through sys-
tems that remind them of themselves in some meaningful
way.
Facilitator role to encourage peer support and self-manage-
ment.
Social role: If a system adopts a social role, users will more
likely use it for persuasive purposes.
Badging via logos endorses clinical services and research
team expertise. Narrator’s voice (Robert) is reassuring.
Trustworthiness and expertise: A system that is viewed as
trustworthy and/or incorporating expertise will have in-
creased powers of persuasion.
Supporting the credibility
of the system
Ease of log-in, secure, simplicity of instructions, and clarity
of format. Up-to-date, easily accessible information and
downloadable resources. In phase II, wider device compati-
bility, addition of frequently asked questions, access to chat
room from every page, easier navigation.
Surface credibility: People make initial assessment of the
system credibility based on a first-hand inspection.
Optional voice over throughout; possibility of contacting
facilitator for private email chat.
Real world: A system that highlights people or organizations
behind its content or services will have more credibility.
Chat forum provides opportunity to interact, to discuss self-
assessment and progress, and to provide or receive support.
Social learning: A person will be more motivated to perform
a target behavior if they can use a system to observe others
performing the behavior
Social support
Participants can compare their experiences with those of
their peers in the films and in the chat forum.
Social comparison: System users will have a greater motiva-
tion to perform the target behavior if they can compare their
performance with the performance of others.
aPSD: persuasive system design. Part of table used with permission from Association for Information Systems, Atlanta, GA; 404-413-7444; All rights
reserved.
Participant Satisfaction
Satisfaction with the program was assessed at post intervention
via an author-generated questionnaire containing 4 Likert-type
scales representing: (1) recruitment, (2) program, (3) chat room,
and (4) films. In-depth telephone interviews were conducted by
the study researcher with 10 phase II participants to understand
personal experiences and contexts. Interviews were audio
recorded, transcribed, and analyzed using framework analysis
[53].
Distress
Screening for distress was measured by the General Health
Questionnaire-28 (GHQ-28) [54]. Performance in cancer
populations shows high reliability (rho≥.80, kappa≥.60, r=.8)
and high validity (≥80%) [55]. Mild and moderate distress was
assessed as a score ≥4.
The PHQ-9 [46] and GAD-7 [47] were administered at baseline
and post intervention in both phases. In phase I, the program’s
week 1 data were used as baseline.
Self-Efficacy
In phase II, the Self-Efficacy for Symptom Control Inventory
(SESCI) was administered at baseline and post intervention to
assess participant self-belief to cope and manage prostate
cancer-related symptoms. The SESCI contains 3 subscales:
self-efficacy for physical function, self-efficacy for coping or
tolerating symptoms, and self-efficacy for symptom
management. Participants indicate how confident they feel on
scales for each domain from 0 (not confident) to 100 (very
confident). The measure is a modified version of a self-efficacy
scale used in chronic pain and lung cancer symptoms [56,57].
For prostate cancer patients, reliability has been calculated with
a Cronbach alpha for the total scale of .97, and for each subscale
of .94 [58].
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Service Implementation
Time spent by the facilitators in the program was assessed by
log-in data. Issues related to delivery and integration in practice
were explored after the intervention: in phase I, the study
researcher conducted face-to-face interviews with the 2
facilitators; in phase II, a telephone interview was conducted
with the facilitator. Issues relating to delivery and integration
into current practice were explored. Interviews were audio
recorded, transcribed, and analyzed with framework analysis
[53].
Data Analysis
We assessed participant demographic, disease, treatment and
satisfaction profiles, and uptake and adherence descriptively.
We used descriptive statistics (mean, median, standard deviation
[SD], interquartile range [IQR]) and box plots to examine the
distribution of distress measured by the GHQ-28 and
self-efficacy. The samples were not powered to detect
significance in the outcome measures, nevertheless we present
nonparametric data in relation to distress and self-efficacy to
aid understanding of the potential effect of the program within
these samples and provide data on which to base a power
calculation for a larger study of efficacy. Statistical testing was
performed on the 2 samples of core users, which for feasibility
testing in this design provides a more useful measure of overall
outcome [48].
Results
Uptake
A total of 14.1% (61/432) of invited men consented to the take
part in phase I, and 12.2% (74/606) of invited men consented
to take part in phase II (Figure 3).
Figure 3. Consolidated Standards of Reporting Trials (CONSORT) diagram of participant flow.
JMIR Cancer 2018 | vol. 4 | iss. 1 | e8 | p.7http://cancer.jmir.org/2018/1/e8/
(page number not for citation purposes)
Cockle-Hearne et alJMIR CANCER
XSL•FO
RenderX
Participants
In phase I, 47 eligible men were screened, of whom 32% (15/47)
were experiencing distress: 21% (10/47) indicated mild and
moderate distress and were offered the intervention and 11%
(5/47) indicated suicidal thoughts and were referred for clinical
assessment.
In phase II, 49 eligible men were screened, of whom 43%
(21/49) were experiencing distress, 41% (20/49) indicated mild
and moderate distress and were offered the intervention, and 1
indicated a suicide risk and was referred for clinical assessment.
Attrition
In phase I, 10 participants were offered and started the
intervention, and 2 withdrew in the first module (1 felt the
program was not appropriate for his needs and 1 gave no reason).
A total of 80% (8/10 across 2 cohorts) remained in the program
for the 4 weeks and completed all assessments (Figure 3).
In phase II, 20 participants were offered the intervention, 1 did
not start (no reason given), and 3 withdrew during the first
module (1 declined because he had been recently bereaved and
2 gave no reason). A total of 80% (16/20 in 1 cohort) remained
in the program for the 4 weeks and completed all assessments
(Figure 3).
User Profiles
Baseline demographic, disease, and treatment characteristics
for core users are reported in Table 3.
Demographics
In phase I, the median age was 68 years; typically, men were
retired or working part-time, educated up to the age of 16 or 18
years without any higher education, and living in least deprived
areas of the region. All were of white ethnicity, living with a
partner, and reported co-existing health conditions.
In phase II, the median age was 62 years; men were typically
living with a partner, retired, or working full-time; a fifth were
on long-term sick leave. All were of white ethnicity, polarized
between most and least deprived areas. All except one reported
co-existing health conditions.
Disease and Treatment
The majority of men in both phases had been diagnosed under
2 years; locally confined disease at diagnosis was reported by
less than half in phase I and by nearly 3 quarters in phase II.
The majority in both phases recalled a PSA at diagnosis >10.
Most men in both phases were undergoing active treatment at
the time of the intervention, either hormone treatment or
hormone plus external beam radiotherapy.
All those who had completed treatment had done so within 1-2
years. In phase I, men had received hormone and or external
beam radiotherapy; in phase II, there was a broad range of
treatment experience, including prostatectomy. A minority in
each phase had experience of active surveillance; 1 man in phase
II was undergoing active surveillance.
Adherence
Task Support
On the basis of page views, 50% (4/8) of men in phase I reached
the end of all the modules. In phase II, 88% (14/16) of men
reached the end of all the modules. This equates to overall
module adherence rates of 63% (mean 2.5, SD 1.9) and 92%,
(mean 3.7, SD 1.0) respectively.
On the basis of a possible 21 CBT entries, there was an
adherence rate of 77% (mean 16.1, SD 6.2) in phase I, and 88%
(mean 18.6, SD 3.9) in phase II. The mood diary in phase II
was completed by 100% (16/16) of men.
Social Support
A total of 6 out of 8 men (75%) in phase I viewed all 4 peer
support films, 1 (1/8) man watched 2 films, and 1 (1/8) man
watched 3 films, equating to an adherence rate of 91% (mean
3.6 SD 0.7). Data available for the 4 weeks of phase II, indicated
a total of 16, 11, 11 and 10 unique weekly views, respectively.
In phase I, 63% (5/8) of men posted in the chat room: median
posts n=2 (range 1-6). In phase II, 75% (12/16) men posted:
median posts n=5 (range 1-24).
Log-in Behavior
In phase I, median time logged in was 5 h 35 min
(range 2 h 38 min to 11 h 31 min). In phase II, median time
logged-in-and-active was 4 h 5 min (range 1 h 8 min to 8 h 33
min).
Participant Satisfaction
Questionnaire responses indicated that the Web-based
recruitment and consent process was understood, appropriate
in language and style, swift to respond, and easy to access (Table
4). Response to the program and the films was also positive,
but there were some issues raised and clarified in open-ended
and qualitative responses that will inform future development.
Issues were related to the following: (1) length of sessions, the
last module Getting There was shorter than the preceding
modules, which was disappointing; (2) questions about suicide
(at screening and assessment) were alarming for some; and (3)
the need to enhance identification with the men in the films by
providing details of what treatments they had received. In phase
I, the chat room was poorly endorsed: it had been difficult to
locate, there had been little activity and opportunity to chat, and
the facilitation was not perceived as supportive. These issues
were addressed in phase II and satisfaction improved: access
and ease of use was enhanced, notifications of chat room activity
were provided, and facilitator interaction was increased.
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Table 3. Core user profiles.
Phase II (N=16)Phase I (N=8)Core user characteristics
64 (6.9)69 (6.1)Age in years, mean (SD)
62 (55-80)68 (61-79)Age in years, median (range)
Age groups, n (%)a
4 (25)0 (0)50-59
9 (56)5 (63)60-69
2 (13)3 (37)70-79
1 (6)0 (0)80-89
Living status, n (%)a
1 (6)0 (0)Alone
15 (94)8 (100)With partner
Working status, n (%)a
5 (31)1 (13)Full-time
0 (0)3 (37)Working part-time
3 (19)0 (0)Long-term sick
7 (44)4 (50)Retired
1 (6)0 (0)Other
Education, n (%)a
12 (75)3 (37)Up to 16 years
1 (6)4 (50)Up to 18 years
2 (13)0 (0)Post 18 years Diploma/certificate
1 (6)1 (13)Higher education
Residential area: EIMDb; SMIDc quintiles, n (%)a
3 (19)0 (0)1 Most deprived
4 (25)1 (13)2
2 (13)2 (25)3
4 (25)3 (37)4
3 (19)2 (25)5 Least deprived
Ethnicity, n (%)a
16 (100)8 (100)White
Comorbidities, n (%)a
1 (6)0 (0)0
6 (38)4 (50)1
2 (13)3 (37)2
4 (25)1 (13)3
3 (19)0 (0)4
Time since diagnosis, n (%)a
7 (44)4 (50)Under 1 year
2 (25)1 (13)1-2 years
5 (31)0 (0)2-3 years
0 (0)1 (13)3-4 years
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Phase II (N=16)Phase I (N=8)Core user characteristics
0 (0)2 (25)5 years +
Stage of disease at diagnosis, n (%)a
8 (50)3 (38)I
3 (19)0 (0)II
4 (25)3 (38)III
1 (6)1 (13)IV
0 (0)1 (13)Missing
PSAd score, n (%)a
0 (0)0 (0)<4
2 (13)1 (13)4-10
13 (81)6 (75)>10
1 (6)1 (13)Missing
Gleason score (biopsy), n (%)a
2 (13)1 (13)6
4 (25)3 (43)7
4 (25)3 (43)8-9
61Missing
Time since active treatment n (%)a
8 (50)5 (63)Current treatment
5 (31)0 (0)Under 1 year
2 (13)3 (37)1-2 years
1 (6)0 (0)Not had active treatment
Treatment receivede, n (%)a
9 (56)0 (0)Prostatectomy
7 (44)4 (50)External beam radiotherapy
1 (6)0 (0)Brachytherapy
10 (63)7 (87)Hormone therapy
6 (38)1 (13)Active surveillance
3 (19)0 (0)Watchful waiting
Current active treatment, n (%)a
8 (50)5 (63)Hormone therapy
2 (13)2 (25)External beam radiotherapy
aPercentages rounded.
bEMID: English Index of Multiple Deprivation (phase I).
cSIMD: Scottish Index of Multiple Deprivation (phase II).
dPSA: prostate-specific antigen.
eParticipants may have had, or be having, more than 1 treatment.
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Table 4. Participant satisfaction.
Phase II (N=16), n (%)aPhase I (N=8), n (%)aProgram elements: Likert Scales
NeutraldDisagreecAgreebNeutraldDisagreecAgreeb
Recruitment pages
0 (0)0 (0)16 (100)0 (0)0 (0)8 (100)Understood the process
1 (6)0 (0)15 (94)0 (0)0 (0)8 (100)Language appropriate
2 (13)0 (0)14 (88)0 (0)0 (0)8 (100)Look appropriate
0 (0)0 (0)16 (100)1 (13)0 (0)7 (88)Emails swift
0 (0)0 (0)16 (100)1 (13)1 (13)6 (75)Links easy to access
The program
1 (6)0 (0)15 (94)0 (0)0 (0)8 (100)Language appropriate
3 (19)2 (13)11 (69)0 (0)1 (13)7 (88)Length of each step right
3 (19)1 (6)12 (75)1 (13)0 (0)7 (88)Week per session right
N/AN/AN/A1 (13)0 (0)7 (88)Questionnaires did not interferee
6 (38)3 (19)7 (44)N/AN/AN/AMood diary was helpfulf
1 (6)0 (0)15 (94)1 (13)1 (13)6 (75)Worked through smoothly
0 (0)0 (0)16 (100)2 (25)0 (0)6 (75)Links easy to access
2 (13)0 (0)14 (88)2 (25)0 (0)6 (75)Information helpful
0 (0)0 (0)16 (100)3 (38)0 (0)5 (63)Understood diagrams
8 (50)1 (6)7 (44)3 (38)0 (0)5 (63)Worksheets useful
5 (31)1 (6)10 (63)4 (50)0 (0)4 (50)Robert’s voice helped me
Chat forum
3 (19)0 (0)13 (81)3 (38)2 (25)3 (38)Easy to locate
7 (44)0 (0)9 (56)5 (63)1 (13)2 (25)Facilitator was supportive
9 (56)0 (0)7 (44)6 (75)1 (13)1 (13)Opportunity for private chat was reassuringg
5 (31)1 (6)10 (63)5 (63)3 (38)0 (0)Learned a lot from other men
Films
1 (6)0 (0)15 (94)1 (13)0 (0)7 (88)Range of experiences and stories
6 (38)0 (0)10 (63)1 (13)0 (0)7 (88)Made me feel not alone
4 (25)0 (0)12 (75)2 (25)0 (0)6 (75)Program benefited from films
1 (6)1 (6)14 (88)3 (38)0 (0)5 (63)Men were representative
3 (19)2 (13)11 (69)1 (13)2 (25)5 (63)Could relate to men
6 (38)0 (0)10 (63)4 (50)0 (0)4 (50)Reflected learning in modules
7 (44)0 (0)9 (56)4 (50)0 (0)4 (50)Gave me confidenceh
aPercentages rounded.
bAgree + agree strongly.
cDisagree + disagree strongly.
dNeither agree nor disagree.
ePhase I only.
fPhase II only.
gFull item Opportunity to have private chat with facilitator was reassuring.
hFull item Gave me confidence to make a difference to how I feel.
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Figure 4. Change in distress. General Health Questionnaire-28 (GHQ-28).
Phase II interviews helped clarify the questionnaire responses.
(Participant profiles: Multimedia Appendix 3; verbatims:
Multimedia Appendix 4). Acceptability of the program was
high, even among those with low IT skills, and there was a
readiness to improve skills. Men were comfortable using tablets,
mobile phones, laptops, and desktop computers: they mainly
found it effortless and flexible in comparison with other forms
of support, even those who were finding concentration, or the
availability of free time, a challenge. Some expectations were
not met: disappointment with the length of modules noted in
the assessment was attributed to less interaction time and things
to do in the final module.
Men readily identified that the program targeted issues they
found difficult to talk about. Learning about the link between
the effects of treatment and mood and behavior was a fresh
perspective, and they felt that the skills developed to manage
now would be useful should things change in the future. Men
referred more consistently, however, to other aspects of the
program. The weekly provision of information via a range of
links related to that week’s learning was used enthusiastically
because it provided access to immediate information that meant
men could control when and how much they consumed. They
identified that having the links was an improvement on their
usual Internet use because they were direct and avoided lengthy
searching and inappropriate or potentially scary information.
The films provided discreet stories, preventing the unpredictable,
which helped men feel connected and in control, particularly
those with social and information needs.
For those who engaged in the chat room, it was a safe
environment where they could be honest with each other without
the inhibitions they often experienced with clinicians. It was
also a source of quick answers to spontaneous questions, which
for some was very appealing; for others, it could be daunting if
something was revealed that was incorrect or alarming. Despite
the improved chat room satisfaction scores in phase II, some
felt that the facilitator could have made more attempts to
encourage men to open up and interact.
Distress
The samples were not powered to detect a significant change.
Notwithstanding, we carried out nonparametric testing to
determine potential for change in distress between baseline and
post intervention; the samples performed similarly (Figure 4).
A Wilcoxon signed-rank test indicated improvement in distress
at the end of the intervention in both phases (phase I z=−2.213,
P=.03, r=−.55; phase II z=−3.342, P=.001, r=−.59). In phase
II, we also calculated change in domain scores. From baseline
to post intervention, there was a positive change in somatic
domain symptoms (z=−2.588, P=.01, r=−.458) and anxiety
domain symptoms (z=−3.466, P=.001, r=−.613). Scores for
social dysfunction domain symptoms were z=−1.531, P=.13,
r=−.27 and for severe depression domain symptoms scores were
z=−1.283, P=.20, r=−.23 (see Multimedia Appendix 5).
Clinical Caseness
A total of 17% (4/24) of participants overall registered scores
on the PHQ-9 and GAD-7 that were above the clinical threshold
for depression and anxiety and defined them as cases requiring
clinical intervention in accordance with IAPT protocols. Of
these 4, 3 scored over the threshold for depression on the PHQ-9,
and 3 scored over the threshold for anxiety on the GAD-7 (see
Multimedia Appendix 6).
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Self-Efficacy Phase II
At baseline, men were most confident in performing daily
activities (mean 69, median 80.0, SD 22.4, range 18-72),
less-confident coping/tolerating symptoms (mean 52, median
53.5, SD 17.2, range 26-80), and least confident managing their
symptoms (mean 31.6, median 31.50, SD 9.3, range 12-49; see
Multimedia Appendix 7). A Wilcoxon signed-rank test
performed on baseline and post scores showed an improvement
in coping (z=−2.329, P=.02, r=−.412). Change was not indicated
in managing symptoms (P=.11) or in performing daily activities
(P=.08).
Service Implementation
Facilitator Time
Phase I facilitator clinical time was ring-fenced for 2, 2-h
sessions per week, that is, 16 h over a 4-week program. To risk
assess and monitor the program at other times, 1 facilitator spent
6 h 56 min in the program and the second spent 8 h 29 min,
giving a total of 22 h 56 min and 24 h 29 min, respectively, per
program. In phase II, the facilitator spent 15 h 45 min in total
across 1 program.
Facilitator Feedback—Delivery
The psychological practitioners were reassured the program
was consonant with their standard CBT practice. They
emphasized that the lay approach did not overwhelm participants
and encouraged active log-in and participant commitment. They
indicated their clients generally found it difficult to differentiate
the effects of physical and psychological symptoms on mood,
and often there was little change on the service’s standard
outcome measures for clients with a physical long-term
condition. In the cancer service, the opportunity to offer
evidenced-based support for distress was welcomed as a
practical and timely benefit for patients; this need was
considered poorly covered in the nurse-patient interaction
through a lack of competences and provision (Verbatims:
Multimedia Appendix 8).
Facilitator Feedback—Implementation
The psychological practitioners found the self-management role
difficult to integrate into their skill set, and they lamented the
move away from their therapeutic expertise. They were
supportive of being allocated time slots for facilitation as it was
necessary for case management, but there had been little need
for them to respond during these times as men’s log-in
preferences did not correspond to their availability. They felt
this impeded the flow of conversation and highlighted the
benefits of providing a rolling chat room rather than starting
afresh each week. Integration into the nurse’s current practice
was challenging; the accepted nurse role of fixer was replaced
in this context by an enablement approach which was unfamiliar
and was considered to require a shift in practice values calling
for bespoke training. Notwithstanding, the ad hoc facilitation
had enabled a flexible response, and the role had been easily
assimilated into the nurse’s workload. In both services, the
facilitator role was considered not to require the higher level
skills associated with psychological practitioner and specialist
nurse roles (Verbatims: Multimedia Appendix 8).
Discussion
Principal Findings
This is the first study, to our knowledge, to assess the feasibility
of delivering Web-based CBT support in clinical settings among
men screened with distress after treatment for prostate cancer.
The Getting Down to Coping Program was embraced and
acceptable to its target users. It can be delivered in a clinical
service and has the potential to provide a therapeutic
psychological service remotely.
Demand
Demand for the program was evident. Among men who were
eligible and screened with mild and moderate distress, 29 of the
30 (96%) started the program. This exceeds reported rates in
comparable cancer and prostate cancer Web-based studies for
distress where enrolment after screening, which excluded
distress, was between 31% and 41% [33,59]. Our retention rate
of 80% meets the 70% criteria for feasible retention set by Yanez
et al [33], and our 20% attrition rate is also at the lower end of
rates found in randomized trials of Internet-based interventions
for anxiety and depression, which range from 1% to 50% [60].
Initial uptake to our invitation of 12-14% among an unscreened
sample, however, was low. Comparison with other Web-based,
distress-related prostate cancer studies is problematic as they
do not report the base numbers from which their screened
samples were drawn [31,33]. Yet this level of uptake is not
completely surprising. Across the spectrum of cancer, the profile
of older age and male gender has been associated with lower
uptake of Web-based psychological support [59]. Furthermore,
mental health–related stigma can deter help-seeking behavior,
particularly in men, and in a clinic environment, it has been
reported that only 20% of unscreened cancer patients accept
psychological help [61,62]. The remote recruitment process we
used would also make it easier for reluctant men to avoid support
[63].
Uptake may be enhanced if the nature and benefits of
psychological support are conveyed so that accepting it is
perceived as less risky. Our recruitment materials were intended
to reduce perceptions of mental health and stigmatizing signals,
but the research focus and length could have been burdensome
for some. Information that is focused on the health problem
rather than the trial process, and that is also brief and relatively
simple, has been associated with enhanced recruitment rates
[64-66]. To involve men, one approach may be to reflect the
way they think and feel about receiving help. In the phase II
interviews, men talked about how they were empowered rather
than how they were supported by the program. This reflects
work by Clover and colleagues who found in a survey among
oncology outpatients the most common barrier to accepting
psychological support was a preference for self-help [67]. The
opportunity for men to increase control of their daily lives by
self-help is a fundamental focus of the Getting Down to Coping
Program and could be incorporated more explicitly into study
communications. Framing the intervention in a self-management
paradigm rather than a psychological one could help normalize
men’s engagement. Further ways to enhance uptake would be
to provide the main component of participant information over
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the internet with interactive elements so that men can choose
what and how much to read. Clinician endorsement of the
program as a self-help opportunity is another component that
could encourage more men to take part [66,68]. The way in
which we communicate psychological Web-based provision
may be a crucial element in encouraging uptake of support and
is an area for further examination [69].
Acceptance
Usage of the program and satisfaction of participants indicated
that it is appropriate and acceptable to its core users. The
adherence rates we achieved, from 63% to 100% across task
and social support elements, illustrated that commitment was
relatively high. In review of Web-based mental health programs,
and in a trial among men with prostate cancer, rates of between
50% and 70% have been reported [31,60]. Men’s satisfaction
and involvement were borne out by their willingness to improve
their IT skills to get the most out of participation. The program
offered experiences that were consonant with masculine ideals,
for instance, being connected, acquiring tools and information,
and a focus on the self, which increased feelings of physical,
social, and emotional control. This is consistent with the notion
that support programs need to reflect masculine ideals to involve
men and optimize benefit [70,71].
We found a larger proportion of men with mild and moderate
distress in the second phase of our research (21% and 41%,
respectively), and also higher adherence rates in this second
phase. There was some previous experience of psychological
support in phase II, and adherence would have been enhanced
by improvements to the program between phases. However, the
higher distress levels and adherence could also be evidence of
a greater level of commitment to the program in men of lower
socio-economic status who characterized the phase II sample.
These men experience poorer access to support and
higher-than-average psychological need, indicating that regional
differences will be an important consideration in further research
and clinical implementation [9,72,73].
Limited Efficacy Testing
We found improvement in distress with a medium-large effect
size in each phase. Particular improvements were in the somatic
and anxiety domains of the GHQ-28. The nature and definition
of distress is complex in a cancer population [74,75], and there
have been calls for a more realistic framework to identify
cancer-related distress [76]. The change in somatic symptoms
confirmed that this can be a factor in the etiology of distress in
a prostate population and is important to include when assessing
distress [77]. The finding that only 4 of our participants would
have been offered standard psychological support on the basis
of assessment with the PHQ-9 and GAD-7, which do not include
somatic symptoms, further suggests that more tailored tools are
required for this population.
We also found an improvement in confidence to cope with
prostate cancer symptoms but not for confidence to perform
daily activities or to manage symptoms. This can be expected;
performing daily activities was at a high level at baseline,
leaving little room for improvement, whereas physical symptoms
related to the longer-term effects of prostate cancer treatment
can often be intractable [78]. Ongoing rehabilitation has to be
focused on building resilience and fostering understanding and
coping with symptoms. The program can offer this focus for
men.
Implementation
Implementing the Getting Down to Coping Program has
potential within both primary and secondary care settings. The
intervention is a self-guided program, but some facilitation is
optimal for risk monitoring and would be expected by a
psychological service. However, the facilitation required calls
for neither advanced psychotherapeutic skills nor high-level
nursing skills, only the ability to perform the core skills
necessary to motivate self-management and to monitor risk. In
both settings, our facilitators were not practiced in
communicating within Web-based support programs, and had
no previous experience of supporting self-management. Our
training contained elements of both, but all the facilitators still
had difficulty performing the role; greater emphasis in training
on facilitating self-management via Web-based interaction is
required. Notwithstanding this, facilitation may be delivered in
either setting by a lower band, health support role.
Although we were not able to assess cost-effectiveness in these
studies, the time spent facilitating in each service suggests that
the flexible model of intervention interaction may have the
greatest potential: it did not disrupt the facilitators’ standard
caseload and, for the sample we had (n=16), amounted to 1 h
per participant per 4-week program. This would be inversely
related to the number of men in each program.
Limitations and Strengths
There are limitations to these studies. The sample sizes were
small and were not powered to detect change, and participants
were not randomized. Generalization of our findings must
therefore be cautious. Where we found change we do not know
what variables are responsible; natural recovery could play a
role and so could extraneous events. Nevertheless, with
feasibility testing in 2 clinical settings, we have developed our
knowledge of both the intervention and research required to
move to the next trial stage. The consistency across our 2
samples on a number of measures, and the effects found, indicate
that larger scale, evaluative research is justifiable. Our further
research will include a longer follow-up period to provide an
indication of maintenance of change, as well as full
cost-effectiveness analysis. Furthermore, we will analyze
covariance in respect of facilitator and group effects.
A strength of our studies was that we incorporated the theoretical
model of PSD [52], which can provide an objective
understanding of adherence. We were able to measure social
and task design elements, which we posited were the most
important features in our intervention for effecting behavior
change. Measuring intended use is reflective of assessing
compliance in face-to-face therapy and has been proposed as
the most realistic reference standard for adherence in Web-based
interventions [50,60]. Analysis on this basis offers more robust
comparability within and across studies than static measures of
exposure, such as log-in data, which are inherently subject to
system and participant ambiguity. For instance, log-in time in
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phase I gave little indication of what interaction took place. In
phase II, we measured time logged-in-and-active, which gave
a clearer indication for adherence purposes, but we still had to
make assumptions, that is, how long a log-in was deemed to
contain active time. Such assumptions are often not reported in
studies. More extensive application of the theoretical
underpinnings of how design and system components can
influence behavior change is called for [79].
Conclusions and Recommendations for Future
Research
To integrate psychological services for cancer patients in the
existing care pathways, interventions that fit with health provider
parameters of care provision are required [75]. Without research
sampling based on defined need, or analysis of implementation
processes, many intervention studies do not provide sufficient
evidence of viability or efficacy [75]. We have taken the first
steps to address this with a Web-based intervention, by assessing
feasibility among a population that requires clinical support and
by providing that support within a clinical practice context.
The program has the potential to fit within a stepped model of
care by providing psychological support for men who are mild
or moderately distressed and who fall within the clinical
parameters for low-intensity support. Addressing these men’s
needs will prevent escalation of symptoms and the need for
higher-intensity therapy. Potentially, this would lead to service
cost savings in terms of reduced physical and mental health
service use.
In a stepped model of therapeutic care, the program requires
low-level facilitation for monitoring risk, which raises cost
implications versus a completely automated system. However,
within the clinical services we researched, risk surveillance was
a mandatory requirement, and the true cost comparison would
be versus a therapist-led, face-to-face, or telephone approach.
The numbers of men who can be supported with the Web-based
program at any one time is subject to economies of scale, and
cost advantage can increase exponentially with the volume of
patients taking part. Furthermore, facilitation need not be carried
out by advanced practitioners, which contributes to delivery
cost advantage. Assigning staff to the facilitator role who possess
appropriate competencies, as well as ensuring their involvement
with and commitment to the innovation, will be crucial to its
success [80].
Clinical effectiveness, and cost-effectiveness in terms of clinical
delivery and health service utilization, need to be tested in an
evaluative research design. Future research should be
underpinned by exploratory enquiry to establish the most
relevant and engaging ways to communicate study and
intervention characteristics for this prostate cancer population.
In future, we hope to develop the Web-based program for men
with other cancers.
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